BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 30846387)

  • 1. Endocavitary treatment for upper tract urothelial carcinoma: A meta-analysis of the current literature.
    Foerster B; D'Andrea D; Abufaraj M; Broenimann S; Karakiewicz PI; Rouprêt M; Gontero P; Lerner SP; Shariat SF; Soria F
    Urol Oncol; 2019 Jul; 37(7):430-436. PubMed ID: 30846387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
    Cutress ML; Stewart GD; Zakikhani P; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Sep; 110(5):614-28. PubMed ID: 22471401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
    Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma.
    Li X; Cui M; Gu X; Fang D; Li H; Qin S; Yang K; Zhu T; Li X; Zhou L; Gao XS; Wang D
    World J Surg Oncol; 2020 May; 18(1):114. PubMed ID: 32473636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.
    Seisen T; Peyronnet B; Dominguez-Escrig JL; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Cowan NC; Kaasinen E; Palou J; van Rhijn BW; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
    Eur Urol; 2016 Dec; 70(6):1052-1068. PubMed ID: 27477528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma.
    Mandalapu RS; Remzi M; de Reijke TM; Margulis V; Palou J; Kapoor A; Yossepowitch O; Coleman J; Traxer O; Anderson JK; Catto J; de la Rosette J; O'Brien T; Zlotta A; Matin SF
    World J Urol; 2017 Mar; 35(3):355-365. PubMed ID: 27233780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upper urinary tract instillations in the treatment of urothelial carcinomas: a review of technical constraints and outcomes.
    Audenet F; Traxer O; Bensalah K; Rouprêt M
    World J Urol; 2013 Feb; 31(1):45-52. PubMed ID: 23007718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation Between Confocal Laser Endomicroscopy (Cellvizio
    Breda A; Territo A; Guttilla A; Sanguedolce F; Manfredi M; Quaresima L; Gaya JM; Algaba F; Palou J; Villavicencio H
    Eur Urol Focus; 2018 Dec; 4(6):954-959. PubMed ID: 28753800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacillus Calmette-Guérin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract.
    Nonomura N; Ono Y; Nozawa M; Fukui T; Harada Y; Nishimura K; Takaha N; Takahara S; Okuyama A
    Eur Urol; 2000 Dec; 38(6):701-4;discussion 705. PubMed ID: 11111187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
    Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.
    Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Kosaka T; Mizuno R; Mikami S; Kikuchi E; Oya M
    Cancer Sci; 2021 Mar; 112(3):1084-1094. PubMed ID: 33368857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease.
    Gakis G; Schubert T; Alemozaffar M; Bellmunt J; Bochner BH; Boorjian SA; Daneshmand S; Huang WC; Kondo T; Konety BR; Laguna MP; Matin SF; Siefker-Radtke AO; Shariat SF; Stenzl A
    World J Urol; 2017 Mar; 35(3):327-335. PubMed ID: 27043218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.
    Rouprêt M; Babjuk M; Burger M; Capoun O; Cohen D; Compérat EM; Cowan NC; Dominguez-Escrig JL; Gontero P; Hugh Mostafid A; Palou J; Peyronnet B; Seisen T; Soukup V; Sylvester RJ; Rhijn BWGV; Zigeuner R; Shariat SF
    Eur Urol; 2021 Jan; 79(1):62-79. PubMed ID: 32593530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinoma.
    Simon CT; Skala SL; Weizer AZ; Ambani SN; Chinnaiyan AM; Palapattu G; Hafez K; Magers MJ; Kaffenberger SD; Spratt DE; Montgomery JS; Morgan TM; Udager AM; Lew M; Mehra R
    Hum Pathol; 2019 Apr; 86():76-84. PubMed ID: 30537495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Neoadjuvant Chemotherapy on Pathologic Response in Patients With Upper Tract Urothelial Carcinoma Undergoing Extirpative Surgery.
    Almassi N; Gao T; Lee B; Stein RJ; Haber GP; Ornstein MC; Rini BI; Gilligan TD; Garcia JA; Stephenson AJ; Grivas P
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1237-e1242. PubMed ID: 30217764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Expanded Use of Percutaneous Resection for Upper Tract Urothelial Carcinoma: A 30-Year Comprehensive Experience.
    Motamedinia P; Keheila M; Leavitt DA; Rastinehad AR; Okeke Z; Smith AD
    J Endourol; 2016 Mar; 30(3):262-7. PubMed ID: 26630130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of intrarenal Bacillus Calmette-Guérin/interferon-α2B for biopsy-proven upper-tract carcinoma in situ.
    Shapiro EY; Lipsky MJ; Cha DY; McKiernan JM; Benson MC; Gupta M
    J Endourol; 2012 Dec; 26(12):1645-50. PubMed ID: 22834939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract].
    Rouprêt M; Zigeuner R; Palou J; Boehle A; Kaasinen E; Sylvester R; Babjuk M; Oosterlinck W;
    Actas Urol Esp; 2012 Jan; 36(1):2-14. PubMed ID: 22036956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephron-sparing management of upper tract urothelial carcinoma.
    Farrow JM; Kern SQ; Gryzinski GM; Sundaram CP
    Investig Clin Urol; 2021 Jul; 62(4):389-398. PubMed ID: 34190434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update.
    Rouprêt M; Seisen T; Birtle AJ; Capoun O; Compérat EM; Dominguez-Escrig JL; Gürses Andersson I; Liedberg F; Mariappan P; Hugh Mostafid A; Pradere B; van Rhijn BWG; Shariat SF; Rai BP; Soria F; Soukup V; Wood RG; Xylinas EN; Masson-Lecomte A; Gontero P
    Eur Urol; 2023 Jul; 84(1):49-64. PubMed ID: 36967359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.